{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:47:25Z","timestamp":1782265645288,"version":"3.54.5"},"reference-count":58,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Amyloidosis is an infiltrative cardiomyopathy caused by amyloid deposition into the myocardium. In recent years, recognition of this treatable cause of heart failure has increased. There are striking sex differences in the diagnosis, clinical course and outcome of the disease. Notably, women have a worse prognosis than men with similar amounts of cardiac involvement. Methods: This review provides an overview of the current state of knowledge regarding the epidemiology, clinical features, diagnosis and treatment of amyloid heart disease. The differences observed between men and women are discussed, and recent advances in the field are highlighted. Results: Compared to men, women are generally older at diagnosis, appear to have less severe cardiac disease at the time of impairment and are more frequently diagnosed late. The less apparent disease manifestations in women may be responsible for the delay in diagnosis. Moreover, women may be underdiagnosed when sex-neutral diagnostic criteria are used. Conclusions: Addressing diagnostic disparities may require the use of sex-specific diagnostic thresholds, as well as a more expansive use of multimodality imaging. Future clinical trials should aim to enroll a greater number of female participants to inform optimal therapeutic approaches and to define the sex-specific disease phenotype for this increasingly treatable disease.<\/jats:p>","DOI":"10.3390\/jcm15124819","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:03:23Z","timestamp":1782263003000},"page":"4819","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Small Hearts, Big Clues: A Narrative Review on Sex-Related Disparities in the Diagnosis and Management of Cardiac Amyloidosis in Women"],"prefix":"10.3390","volume":"15","author":[{"given":"Ilenia","family":"Monaco","sequence":"first","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier General Victor Jousselin de Dreux, 28100 Dreux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mounia","family":"Sedrati","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier General Victor Jousselin de Dreux, 28100 Dreux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insaf","family":"Chouarfia","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier General Victor Jousselin de Dreux, 28100 Dreux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima Zahra Samet","family":"Bouhaik","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier General Victor Jousselin de Dreux, 28100 Dreux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Trivelloni","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier General Victor Jousselin de Dreux, 28100 Dreux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassine","family":"Bencharef","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier General Victor Jousselin de Dreux, 28100 Dreux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Fouad","family":"Sekkal","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier General Victor Jousselin de Dreux, 28100 Dreux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1646-2196","authenticated-orcid":false,"given":"Dario","family":"Bottigliero","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier General Victor Jousselin de Dreux, 28100 Dreux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"ehaf784.1006","DOI":"10.1093\/eurheartj\/ehaf784.1006","article-title":"Gender differences in cardiac transthyretin amyloidosis: Diagnostic gap in female patients","volume":"46","author":"Vogel","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"ehaf784.2735","DOI":"10.1093\/eurheartj\/ehaf784.2735","article-title":"Wild-type transthyretin cardiac amyloidosis: Sex differences in prevalence, phenotype, and prognosis","volume":"46","author":"Zaroui","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-based treatment for immunoglobulin light-chain amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-med-052918-020140","article-title":"Cardiac Amyloidosis: Overlooked, underappreciated, and treatable","volume":"71","author":"Rubin","year":"2020","journal-title":"Annu. Rev. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: Evolving diagnosis and management: A scientific statement from the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100720","DOI":"10.1016\/j.blre.2020.100720","article-title":"The diagnostic challenges of cardiac amyloidosis: A practical approach to the two main types","volume":"45","author":"Varga","year":"2021","journal-title":"Blood Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/j.jacc.2020.04.022","article-title":"Cardiac scintigraphy with technetium-99m-labeled bone-seeking tracers for suspected amyloidosis: JACC review topic of the week","volume":"75","author":"Hanna","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Teresi, L., Trimarchi, G., Liotta, P., Restelli, D., Licordari, R., Carciotto, G., Francesco, C., Crea, P., Dattilo, G., and Micari, A. (2024). Electrocardiographic Patterns and Arrhythmias in Cardiac Amyloidosis: From Diagnosis to Therapeutic Management\u2014A Narrative Review. J. Clin. Med., 13.","DOI":"10.3390\/jcm13185588"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zhang, L., Jiao, Y., and Guo, J. (2026). Biomolecular mechanisms of cardiac amyloidosis and its cardiovascular pathological basis. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1832739"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijcard.2022.12.048","article-title":"Evolving epidemiology of transthyretin amyloid cardiomyopathy due to increased recognition in women","volume":"374","author":"Prasad","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.amjcard.2024.11.019","article-title":"The impact of active ascertainment on sex-specific differences in the prevalence and phenotype of transthyretin cardiac amyloidosis: The SCAN-MP study","volume":"237","author":"Chan","year":"2025","journal-title":"Am. J. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ihne-Schubert, S.M., Leberzammer, M., Weidgans, M., Frantz, S., Einsele, H., Knop, S., Schubert, T., Bratan, T., St\u00f6rk, S., and Neuderth, S. (2024). Single German centre experience with patient journey and care-relevant needs in amyloidosis: The German AMY-NEEDS research and care program. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0297182"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"101086","DOI":"10.1016\/j.jacadv.2024.101086","article-title":"Age- and sex-related differences in patients with wild-type transthyretin amyloidosis","volume":"3","author":"Dispenzieri","year":"2024","journal-title":"JACC Adv."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijcard.2019.12.063","article-title":"Diagnostic delay in wild type transthyretin cardiac amyloidosis\u2014A clinical challenge","volume":"304","author":"Ladefoged","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"107242","DOI":"10.1016\/j.medcli.2025.107242","article-title":"Clinical presentation and prognosis of transthyretin cardiac amyloidosis according to gender. Analysis of the Galician registry of cardiac amyloidosis (AMIGAL)","volume":"166","year":"2026","journal-title":"Med. Clin."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.15507\/3034-6231.001.202501.032-040","article-title":"Cardiac Arrhythmias and Conduction Disorders in Geriatric Patients with Cardiovascular Comorbidity","volume":"1","author":"Vlasova","year":"2025","journal-title":"Med. Biotechnol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"A15165","DOI":"10.1161\/circ.142.suppl_3.15165","article-title":"Abstract 15165: Routine ambulatory heart rhythm monitoring in patients with transthyretin cardiac amyloidosis","volume":"142","author":"Dale","year":"2020","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1002\/ejhf.2646","article-title":"Sex differences among patients with transthyretin amyloid cardiomyopathy\u2014From diagnosis to prognosis","volume":"24","author":"Patel","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_19","first-page":"321","article-title":"Expert Center for cardiac amyloidosis: Reality and perspectives","volume":"96","author":"Nasonova","year":"2024","journal-title":"Ter. Arkhiv"},{"key":"ref_20","first-page":"S36","article-title":"Sex differences in cardiac amyloidosis: A clustering-based analysis","volume":"119","author":"Zaroui","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2024-200911","article-title":"Clinical characteristics and therapeutic response of patients with heavy chain (AH) and heavy and light chain (AHL) Amyloidosis","volume":"144","author":"Li","year":"2024","journal-title":"Blood"},{"key":"ref_22","first-page":"30","article-title":"Left ventricular wall thickness and derived parameters in cardiac amyloidosis","volume":"94","author":"Finet","year":"2025","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"D118","DOI":"10.1093\/eurheartjsupp\/suad111.282","article-title":"P206 Do we need lower cut\u2013offs of left ventricular wall thickness to suspect cardiac transthyretin amyloidosis in women?","volume":"25","author":"Aimo","year":"2023","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10741-023-10339-w","article-title":"Sex differences in transthyretin cardiac amyloidosis","volume":"29","author":"Aimo","year":"2023","journal-title":"Heart Fail. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Pugliatti, P., Trimarchi, G., Barocelli, F., Pizzino, F., Di Spigno, F., Tedeschi, A., Piccione, M.C., Irrera, P., Aschieri, D., and Niccoli, G. (2024). Advancing Cardiac Amyloidosis Care Through Insights from Cardiopulmonary Exercise Testing. J. Clin. Med., 13.","DOI":"10.3390\/jcm13237285"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"ehaf784.2762","DOI":"10.1093\/eurheartj\/ehaf784.2762","article-title":"Assessing functional capacity in patients with ATTR-CM: The role of CPET and 6MWT","volume":"46","author":"Sheikh","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Rozenbaum, Z., Granot, Y., Sadeh, B., Havakuk, O., Arnold, J.H., Shimiaie, J., Ghermezi, M., Barak, O., Ben Gal, Y., and Shacham, Y. (2023). Sex differences in heart failure patients assessed by combined echocardiographic and cardiopulmonary exercise testing. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1098395"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e70308","DOI":"10.14814\/phy2.70308","article-title":"Ventilatory efficiency in cardiac amyloidosis\u2014A systematic review and meta-analysis","volume":"13","author":"Willixhofer","year":"2025","journal-title":"Physiol. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/CIRCULATIONAHA.105.541078","article-title":"Age- and Gender-Related Ventricular-Vascular Stiffening: A Community-Based Study","volume":"112","author":"Redfield","year":"2005","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"ehaf784.2708","DOI":"10.1093\/eurheartj\/ehaf784.2708","article-title":"Sex-based differences in phenotypic expression and prognosis of transthyretin cardiac amyloidosis associated with the Val122Ile variant","volume":"46","author":"Monfort","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.cardfail.2020.06.009","article-title":"Prior carpal tunnel syndrome and early concomitant echocardiographic findings among patients with cardiac amyloidosis","volume":"26","author":"Abelow","year":"2020","journal-title":"J. Card. Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"ehaf784.2725","DOI":"10.1093\/eurheartj\/ehaf784.2725","article-title":"Unraveling gender differences in hereditary transthyretin amyloidosis: Insights from the REACT registry","volume":"46","author":"Freire","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","article-title":"Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release","volume":"72","author":"Sperry","year":"2018","journal-title":"JACC"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"qyaf148","DOI":"10.1093\/ehjimp\/qyaf148","article-title":"RWT\/SaVR ratio displays Strong Diagnostic Performance to identify Transthyretin Amyloid Cardiomyopathy in Females: Implications for Sex-Specific Echocardiographic Thresholds","volume":"3","author":"Lindqvist","year":"2025","journal-title":"Eur. Heart J. Imaging Methods Pract."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"ehaf784.2559","DOI":"10.1093\/eurheartj\/ehaf784.2559","article-title":"A systematic review and meta-analysis of diagnostic performance of various echocardiographic parameters in cardiac amyloidosis","volume":"46","author":"Pagourelias","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Nardi, E., Gagliardo, C.M., Noto, D., Barbagallo, C.M., Giammanco, A., Di Rosa, G., Bellini, F., Averna, M., and Cefal\u00f9, A.B. (2026). Echocardiographic Red Flags in Wild-Type Transthyretin Amyloidosis: Sex-Specific Gaps for Wall Thickness and Left Ventricular Mass. Life, 16.","DOI":"10.3390\/life16020237"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.amjcard.2020.07.050","article-title":"Natural history and disease progression of early cardiac amyloidosis evaluated by echocardiography","volume":"133","author":"Eisen","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"de Gregorio, C., Trimarchi, G., Faro, D.C., Poleggi, C., Teresi, L., De Gaetano, F., Zito, C., Lofrumento, F., Koniari, I., and Licordari, R. (2024). Systemic Vascular Resistance and Myocardial Work Analysis in Hypertrophic Cardiomyopathy and Transthyretin Cardiac Amyloidosis with Preserved Left Ventricular Ejection Fraction. J. Clin. Med., 13.","DOI":"10.20944\/preprints202403.0569.v1"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jcmg.2024.05.004","article-title":"Myocardial characteristics, cardiac structure, and cardiac function in systemic light-chain amyloidosis","volume":"17","author":"Clerc","year":"2024","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcmg.2019.03.026","article-title":"Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis","volume":"13","author":"Baggiano","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00392-020-01771-1","article-title":"Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: A multi-centre study","volume":"110","author":"Chatzantonis","year":"2020","journal-title":"Clin. Res. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Akg\u00fcn, E., Al\u00e7\u0131n, G., \u015eahin, \u00d6.F., \u015eahin, D., Kaya, M.E., Yaran, S.G., \u015ein, C., Topuz, \u00d6.V., Akka\u015f, B.E., and Kaya, M. (2026). Physiological differences in bone uptake of [99mTc]Tc-pyrophosphate in men and women undergoing cardiac scintigraphy. J. Nucl. Cardiol., 102654.","DOI":"10.1016\/j.nuclcard.2026.102654"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jcmg.2020.08.027","article-title":"Diagnosing transthyretin cardiac amyloidosis by technetium 99m pyrophosphate: A test in evolution","volume":"14","author":"Poterucha","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"42609","DOI":"10.31083\/RCM42609","article-title":"A Comprehensive Review of the Management of Light-Chain (AL) and Transthyretin (ATTR) Cardiac Amyloidosis","volume":"26","author":"Alkhatib","year":"2025","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"ehaf784.2742","DOI":"10.1093\/eurheartj\/ehaf784.2742","article-title":"Anemia and outcome in cardiac amyloidosis","volume":"46","author":"Imperatore","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/eurheartj\/ehz905","article-title":"Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis","volume":"41","author":"Chacko","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/ehjci\/jeae070","article-title":"Sex-and age-related variations in myocardial tissue composition of the healthy heart: A native T1 mapping cohort study","volume":"25","author":"Myhr","year":"2024","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"39331","DOI":"10.1038\/s41598-025-23059-y","article-title":"Exploring sex differences in myocardial fibrosis in patients with structurally normal hearts","volume":"15","author":"Mazur","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcmg.2020.05.031","article-title":"[18F]-florbetaben PET\/CT for differential diagnosis among cardiac immunoglobulin light chain, transthyretin amyloidosis, and mimicking conditions","volume":"14","author":"Genovesi","year":"2021","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"oeaf175","DOI":"10.1093\/ehjopen\/oeaf175","article-title":"Sex-specific differences in cardiac transthyretin amyloidosis: Addressing the diagnostic gap in women","volume":"6","author":"Vogel","year":"2025","journal-title":"Eur. Heart J. Open"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.healun.2020.01.1192","article-title":"Understanding the relationships of cardiac diagnostics in patients with amyloid transthyretin cardiac amyloidosis","volume":"39","author":"Gustafson","year":"2020","journal-title":"J. Heart Lung Transplant."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood.2023022399","article-title":"Complete responses in AL amyloidosis are unequal: The impact of free light chain mass spectrometry in AL amyloidosis","volume":"143","author":"Bomsztyk","year":"2024","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/TCRM.S185677","article-title":"Diagnosis and screening of patients with hereditary transthyretin amyloidosis (hATTR): Current strategies and guidelines","volume":"16","author":"Benson","year":"2020","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1182\/blood-2020-138530","article-title":"Dartumumab in pretreated AL amyloidosis: A systematic review","volume":"136","author":"Ansar","year":"2020","journal-title":"Blood"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood-2020-143106","article-title":"Efficacy and safety profile of proteasome inhibitor based drug regimens for treatment of newly diagnosed AL amyloidosis: A systematic review","volume":"136","author":"Javed","year":"2020","journal-title":"Blood"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41408-019-0266-9","article-title":"Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: A pooled analysis","volume":"10","author":"Warsame","year":"2020","journal-title":"Blood Cancer J."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Chaudhari, M., and Ashwath, M.L. (2025). Multimodality Imaging in Cardiac Amyloidosis. J. Clin. Med., 15.","DOI":"10.3390\/jcm15010163"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.carrev.2025.02.005","article-title":"Outcomes of aortic stenosis in patients with cardiac amyloidosis: A systematic review and meta-analysis","volume":"73","author":"Ahmad","year":"2025","journal-title":"Cardiovasc. Revascularization Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4819\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:28:13Z","timestamp":1782264493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":58,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcm15124819"],"URL":"https:\/\/doi.org\/10.3390\/jcm15124819","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]}}}